E-LIB Suche - Ergebnisse für: Hyland, Robert H.

1

Efficacy and Safety of Remdesivir in People With Impaired K..:

Sise, Meghan E ; Santos, Jose Ramon ; Goldman, Jason D...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

2

Pharmacokinetics, Mass Balance, Safety, and Tolerability of..:

Anoshchenko, Olena ; Abdelghany, Mazin ; Lichtman, Amos...
Clinical Pharmacology & Therapeutics. , 2024

Link: https://doi.org/10.1002/..

3

539. Efficacy in Multiple SARS-CoV-2 Animal Models Supports..:

Pitts, Jared ; Babusis, Darius ; Humeniuk, Rita...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

4

538. Clinical Evaluation of Drug-drug Interactions with Rem..:

Peng, Chi-Chi ; Shelton, Mark ; Raut, Anuja...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

5

506. Resistance Analyses from the Remdesivir Phase 3 REDPIN..:

Andreatta, Kristen ; Li, Jiani ; Rodriguez, Lauren...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

6

524. Hepatic Safety of Remdesivir Across Phase 3 Placebo-co..:

Force, Lindsey ; Blair, Chris ; Duckworth, Joshua...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

7

LB1. Remdesivir for the Treatment of High-Risk Non-Hospital..:

Hill, Joshua A ; Paredes, Roger ; Vaca, Carlos...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S806-S807 , 2021

Link: https://doi.org/10.1093/..

8

548. Baseline characteristics associated with clinical impr..:

Castagna, Antonella ; Hui, David Shu Cheong ; Mullane, Kathleen M...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S340-S340 , 2020

Link: https://doi.org/10.1093/..

9

557. Impact of Concomitant Hydroxychloroquine Use on Safety..:

Arribas, Jose Ramon ; Arribas, Jose Ramon ; Sanyal, Arun J...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S343-S344 , 2020

Link: https://doi.org/10.1093/..

10

72. Remdesivir vs Standard Care in Patients with Moderate c..:

Marty, Francisco M ; Malhotra, Prashant ; Gottlieb, Robert L...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S166-S167 , 2020

Link: https://doi.org/10.1093/..

11

561. Safety of Remdesivir vs Standard Care in Patients with..:

Criner, Gerard J ; Criner, Gerard J ; Ahn, Mi Young...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S345-S346 , 2020

Link: https://doi.org/10.1093/..

12

Tu1501 – Ledipasvir/Sofosbuvir for 8, 12, Or 24 Weeks is Sa..:

Chuang, Wan-Long ; Hu, Tsung-Hui ; Buggisch, Peter...
Gastroenterology. 156 (2019) 6 - p. S-1344 , 2019

Link: https://doi.org/10.1016/..

13

Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV w..:

Ruane, Peter ; Strasser, Simone I. ; Gane, Edward J....
Journal of Viral Hepatitis. 26 (2019) 6 - p. 770-773 , 2019

Link: https://doi.org/10.1111/..

14

Sofosbuvir–velpatasvir single-tablet regimen administered f..:

Sood, Ajit ; Duseja, Ajay ; Kabrawala, Mayank...
Hepatology International. 13 (2019) 2 - p. 173-179 , 2019

Link: https://doi.org/10.1007/..

15

Identification of 19 Novel Hepatitis C Virus Subtypes—Furth..:

Hedskog, Charlotte ; Parhy, Bandita ; Chang, Silvia...
Open Forum Infectious Diseases. 6 (2019) 3 - p. , 2019

Link: https://doi.org/10.1093/..